A 23-year-old man with classic Hodgkin lymphoma (cHL) involving multiple lymph nodes, stage IIIB, International Prognostic Score 5, was treated with adriamycin, bleomycin, vinblastine, and dacarbazine, with a partial response. By the end of chemotherapy, his B symptoms resolved, but he had a new inguinal rash with pruritus. A computed tomography scan revealed bilateral inguinal bulky lymphadenopathy. A punch biopsy showed fragments of skin with multiple foci of lymphoid infiltrate (panel A; original magnification ×40, hematoxylin and eosin [H&E] stain) composed of numerous Reed-Sternberg and Hodgkin-like cells on a background of small lymphocytes and eosinophils (panel B; original magnification ×200; inset, original magnification ×1000; H&E stain). Immunohistochemical stains showed that the large neoplastic cells are positive for PAX5 (dim) (panel C; original magnification ×400), CD3 (focally) (panel D; original magnification ×1000), and CD15 and CD30 (panel E; original magnification ×40; inset, original magnification ×1000) and negative for CD2, CD4, CD5, CD7, CD8, CD20, CD45, and ALK-1. In situ hybridization for Epstein-Barr virus was negative. These histologic and immunophenotypic findings support the diagnosis of recurrent cHL.
This interesting case demonstrates skin involvement by cHL with CD3 expression. Because cHL has a 0.5% to 3% chance of involving skin and a 5% chance of expressing T cell markers, it is extremely rare to see both of these events in the same patient.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal